Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 17, Number 12—December 2011
Letter

Rift Valley and West Nile Virus Antibodies in Camels, North Africa

Mehdi El-Harrak, Raquel Martín-Folgar, Francisco Llorente, Paloma Fernández-Pacheco, Alejandro Brun, Jordi Figuerola, and Miguel Ángel Jiménez-ClaveroComments to Author 
Author affiliations: Biopharma, Rabat, Morocco (M. El-Harrak); Centro de Investigación en Sanidad Animal, Valdeolmos, Spain (R. Martín-Folgar, F. Llorente, P. Fernández-Pacheco, A. Brun, M.Á. Jiménez-Clavero); Estación Biológica de Doñana, Seville, Spain (J. Figuerola)

Main Article

Table

Results of testing of camels for virus antibodies, by location, age group, and sex of camels examined, North Africa, 2009*

Camel characteristic No. samples No. positive for antibody
RVFV WNV AHSV RVFV and WNV
Origin
Tata 2 0 0 0 0
Smara-Laayoune 58 13 20 0 11
Dakhla 40 2 9 0 1
Age group, y
<1 18 1 1 0 1
1–2 25 0 1 0 0
3–5 7 1 3 0 1
6–10 27 6 12 0 10
>10 23 7 12 0 0
Sex
M 71 10 15 0 7
F 29 5 14 0 5
Total 100 15 29 0 12

*RVFV, Rift Valley fever virus; WNV, West Nile virus; AHSV, African horse sickness virus.

Main Article

Page created: November 18, 2011
Page updated: November 18, 2011
Page reviewed: November 18, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external